Harbin Gloria Pharmaceuticals Co., Ltd operates in the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Harbin Gloria Pharmaceuticals Co., Ltd with three other
companies in this sector in China:
Jiangsu Kanion Pharmaceutical Co., Ltd.
sales of 2.82 billion Chinese Renmimbi [US$409.69 million]
of which 100%
was Exportation Trade),
Shanghai Shyndec Pharmaceutical Co Ltd
(2.68 billion Chinese Renmimbi [US$389.60 million]
of which 74%
was Drug Products), and
Jiangzhong Pharmaceutical Company Limited
(2.60 billion Chinese Renmimbi [US$377.10 million]
of which 68%
was Medical Industry).
Harbin Gloria Pharmaceuticals Co., Ltd reported sales of 2.70 billion Chinese Renmimbi (US$392.21 million)
December of 2015.
increase of 41.7%
versus 2014, when the company's sales were 1.91 billion Chinese Renmimbi.
This was the fourth straight year of sales growth at Harbin Gloria Pharmaceuticals Co., Ltd.
Sales of Pharmaceutical Research and Clinical Servi saw an increase
that was more than double the company's growth rate: sales were up
93.1% in 2015, from
18.18 million Chinese Renmimbi to 35.10 million Chinese Renmimbi.
Not all segments of Harbin Gloria Pharmaceuticals Co., Ltd experienced an increase in sales in 2015:
sales of Other Operation fell 4.4% to 16.51 million Chinese Renmimbi.
(However, this segment's sales were only a very small portion of the company's overall sales).